ErasmusMC
Rotterdam, South Holland, 3015CE, Netherlands
NCT Number: NCT02805621
Demonstrate in a large multicenter population the diagnostic performance of a pre-commercial on-site, local, CT angiography derived FFR algorithm in comparison to invasive FFR.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rotterdam, South Holland, 3015CE, Netherlands
To retrospectively evaluate the diagnostic accuracy of FFRCT, in patients with known or suspected CAD. the investigators propose to do technical assessment of the software and evaluate how different parameters effect the outcome. Validate the FFTCT outcome by comparing the FFRCT values with invasive FFR values from retrospective patient data. To analyze the potential of FFRCT on decision making and prognosis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 12 months
Erasmus Medical Center
Other
Machine leArning Based CT angiograpHy derIved FFR a Multi-ceNtEr, Registry
Acronym: Machine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06226948
Arterial Occlusive Diseases, Arteriosclerosis
Maribor, Slovenia
View Trial DetailsNCT01894152
Angioplasty, Arterial Occlusive Diseases
Santa Clara, California, United States
View Trial DetailsNCT03629158
Arterial Occlusive Diseases, Arteriosclerosis
Orlando, Florida, United States
View Trial Details